FDA
- Marketing authorisation holder: IMMUNEX
- Status: approved
🇺🇸 Nozinan in United States
Nozinan (LEVOMEPROMAZINE) regulatory status in United States.
Marketing authorisations
FDA
- Application: NDA015865
- Marketing authorisation holder: IMMUNEX
- Local brand name: LEVOPROME
- Indication: INJECTABLE — INJECTION
- Status: approved
Nozinan in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Nozinan approved in United States?
Yes. FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for Nozinan in United States?
IMMUNEX holds the US marketing authorisation.